These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Effect of aminoglutethimide on ACTH plasma levels in Cushing's disease and Nelson syndrome]. Kasperlik-Załuska AA, Migdalska B, Jeske W, Niegowska E, Wiśniewska-Woźniak T. Pol Tyg Lek; 1987 Sep; 47(44-45):1006-8. PubMed ID: 1339054 [Abstract] [Full Text] [Related]
24. Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications. Gold PW, Loriaux DL, Roy A, Kling MA, Calabrese JR, Kellner CH, Nieman LK, Post RM, Pickar D, Gallucci W. N Engl J Med; 1986 May 22; 314(21):1329-35. PubMed ID: 3010108 [Abstract] [Full Text] [Related]
26. Lack of responsiveness to bromocriptine of Cushing's disease elevated ACTH. del Arbol JL, López-Luque A, Jiménez J, Escobar F, Peña A, Arcelus I, Osorio C. Arch Farmacol Toxicol; 1977 Aug 22; 3(2):171-6. PubMed ID: 200187 [No Abstract] [Full Text] [Related]
27. ACTH response to corticotropin releasing hormone in Cushing's disease before and after ketoconazole: in vivo and in vitro studies. Boscaro M, Sonino N, Rampazzo A, Menegus AM, Mantero F. Horm Metab Res Suppl; 1987 Aug 22; 16():60-2. PubMed ID: 2832292 [Abstract] [Full Text] [Related]
28. Cyproheptadine therapy in Cushing's disease and Nelson's syndrome. Jialal I, Pillay NL. S Afr Med J; 1980 Mar 01; 57(9):305. PubMed ID: 7355345 [No Abstract] [Full Text] [Related]
29. Suppression of ACTH by cortisol in dexamethasone-nonsuppressible Cushing's disease. Carey RM. N Engl J Med; 1980 Jan 31; 302(5):275-9. PubMed ID: 6243171 [No Abstract] [Full Text] [Related]
30. The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome. Chrousos GP, Schulte HM, Oldfield EH, Gold PW, Cutler GB, Loriaux DL. N Engl J Med; 1984 Mar 08; 310(10):622-6. PubMed ID: 6319991 [Abstract] [Full Text] [Related]
31. Lack of effect of antiserotoninergic and/or dopaminergic treatment in patients with pituitary-dependent Cushing's syndrome. Ambrosi B, Gaggini M, Secchi F, Faglia G. Horm Metab Res; 1979 Apr 08; 11(4):318-9. PubMed ID: 222663 [No Abstract] [Full Text] [Related]
32. Cushing's disease, a pituitary disorder. A hypothesis. Zafar MS, Mellinger RC. Henry Ford Hosp Med J; 1980 Apr 08; 28(2-3):138-41. PubMed ID: 6270039 [No Abstract] [Full Text] [Related]
37. [Use of cyproheptadine (Peritol) as a drug blocking corticotropin secretion in the treatment of Cushing's syndrome]. Komissarenko IV, Cheban AK, Rybakov SI, Pomerantsev IuV, Slavnov VI. Probl Endokrinol (Mosk); 1981 Apr 13; 27(6):39-42. PubMed ID: 6275378 [Abstract] [Full Text] [Related]